4th Jun 2025 08:07
GSK PLC - London-based pharmaceutical company - Starts on Wednesday the second tranche of its previously announced GBP2.0 billion share buyback programme. The new tranche, worth up to GBP450.0 million, follows the completion of a first tranche of GBP700.0 million on Tuesday. Merrill Lynch International will run the second tranche, after Citigroup Global Markets Ltd ran the first. It will be completed by September 19. Shares bought will be held in treasury.
Current stock price in London: 1,481.50 pence
12-month change: down 8.3%
By Eva Castanedo, Alliance News reporter
Comments and questions to [email protected]
Copyright 2025 Alliance News Ltd. All Rights Reserved.
Related Shares:
Glaxosmithkline